Search Results - "bisphosphonates"

Engineered Biomimetic Nanomedicine for Enhanced Bone Marrow Targeted Delivery and Therapy in Multiple Myeloma

Xu, Mengyuan, Zhang, Xiaoqian, Zou, Xindi, Feng, Jiawei, Liang, Haitao, Chen, Tingting, Zhong, Tao, Li, Limin

Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway

Gori, Stefania^{Aff1, IDs40487025003435_cor1}, Fabi, Alessandra, Procopio, Giuseppe, Airoldi, Mario, Zambelli, Alberto, Lanzetta, Gaetano, Bracarda, Sergio, Foglietta, Jennifer, Leo, Silvana, Baggi, Anna, Franzini, Jean Marie, Valerio, Matteo, Verzè, Matteo, Nicolis, Fabrizio

Osteoporosis medication use over time in the United States and Canada

Hayes, Kaleen N.^{Aff1, Aff2, Aff3, IDs00198025074843_cor1}, Zullo, Andrew R.^{Aff1, Aff2}, Berry, Sarah D.^{Aff4, Aff5}, Oganisian, Arman, Aggarwal, Sulbh^{Aff3, Aff7}, Adegboye, Michael, Cadarette, Suzanne M.^{Aff3, Aff7, Aff8}

Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk

Rippl, Michaela^{Aff1, IDs0019802507540y_cor1}, Grupp, Pauline, Martini, Sebastian, Müller, Katharina, Schluessel, Sabine, Schmidmaier, Ralf, Tausendfreund, Olivia, Tümena, Thomas, Drey, Michael

A practical use of bone turnover markers in management of patients with skeletal fragility

Brunetti, Alessandro, Cellini, Miriam, Vitale, Valentina^{Aff2, Aff3}, Gentile, Lucrezia Maria Silvana^{Aff2, Aff3}, Birtolo, Maria Francesca^{Aff2, Aff3}, Vescini, Fabio, Lania, Andrea Gerardo^{Aff2, Aff3, IDs1202002504275y_cor1}, Mazziotti, Gherardo^{Aff2, Aff3}

Unitized Nail–Plate Construct (NPC) for Atypical Femur Fracture Fixation: A Retrospective Study on Clinical Outcomes

Shetty, Vivek, Agashe, Vikas, Mishra, Shaswat^{Aff1, IDs43465025013964_cor1}, Kambli, Mrinal, Jain, Manish, Dhawale, Raunak

Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment

Singleton, Miller^{Aff1, IDs1186402501312w_cor1}, Tam, Kevin, Weiner, Ashley, Clark, Leslie H.

Konservative Therapie von Osteonekrosen und Knochenmarködemen an Fuß und Sprunggelenk

Nonoperative treatment for the management of osteonecrosis and bone marrow oedema of the foot and ankle

Horas, Konstantin^{Aff1, IDs0013202504622x_cor1}, Eidmann, Annette, Stratos, Ioannis, Rak, Dominik, Rudert, Maximilian^{Aff1, Aff2}

Production of therapeutic radionuclides for bone-seeking radiopharmaceuticals to meet clinical exigency and academic research

Dash, Ashutosh, Das, Tapas^{Aff1, Aff2, IDs10967025100251_cor1}

Wissenswertes zur medikamentösen Osteoprotektion in der Uroonkologie

Things worth knowing about drug-based osteoprotection in uro-oncology

Thomas, Christian^{Aff1, IDs00120025025237_cor1}, Baunacke, Martin

Comparative analysis of risedronate and its regioisomers synthesized via microwave-assisted method: bone affinity, cytotoxicity, permeability, and therapeutic potential

Zielińska, Monika^{Aff1, IDs4344002500703y_cor1}, Pacholak, Amanda, Orwat, Bartosz^{Aff2, Aff3, Aff4}, Sandomierski, Mariusz, Kownacki, Ireneusz^{Aff3, Aff4}, Kaczorek, Ewa, Voelkel, Adam

Osteoclast in CRPS: an alleged guilty fully acquitted

Varenna, Massimo^{Aff1, IDs00198025074152_cor1}, Zucchi, Francesca, Di Taranto, Raffaele, Orsini, Francesco, Crotti, Chiara

Behandlung von nephrologischen und ossären Komplikationen beim multiplen Myelom

Treatment of nephrological and osseous complications of multiple myeloma

Kus, Jan, Niewald, Marius, de Bra, Stephan, Schinke, Maximilian, Knüttel, Marcel, Wenger, Sina, Schäfer, Henning, Herget, Georg, Wäsch, Ralph, Engelhardt, Monika^{Aff1, IDs00761024016562_cor1}

Inhibition of choroidal osteoma progression using bisphosphonate and RANKL-inhibitory treatment.

Hébert, Mélanie, Babic, Kelly, Hsiao, Edward, Afshar, Armin, Acharya, Nisha, Gonzales, John

application/pdf

Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.

Adesina, Oyebimpe, Jenkins, Isaac, Galvão, Fábio, de Moura, Ana, Fertrin, Kleber, Zemel, Babette, Saad, Sara

application/pdf

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Kelliher, John^{Aff1, Aff2, IDs00256024047389_cor1}, Rahmani, George, Carey, John J.^{Aff1, Aff2}, Bergin, Diane^{Aff1, Aff2}

Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study

Yukishima, Toshitaka^{Aff1, Aff2}, Ebina, Kosuke^{Aff3, Aff4, IDs00198025073864_cor1}, Etani, Yuki, Noguchi, Takaaki, Ohmura, Shin-ichiro, Nakata, Ken, Okada, Seiji, Kobayakawa, Tomonori

Clinical experience with denosumab discontinuation

Laursen, Natasha^{Aff1, Aff2, IDs00198024073517_cor1}, Sølling, Anne Sophie, Harsløf, Torben, Langdahl, Bente^{Aff1, Aff2}

Leitlinie Osteoporose 2023 – Differenzialtherapie – welches Medikament für wen?

Osteoporosis Guideline 2023—Differentiated Therapy—Which Pharmacological Treatment for Whom?

Schulz, Nils^{Aff1, IDs12688024007566_cor1}, Lange, Uwe, Klemm, Philipp

^99mTc-radiolabeling study of 2-amino-3-(4-hydroxyphenyl)-1-hydroxypropyl-1,1-bisphosphonic acid as a potential bone imaging agent

Hamouda, Walid^{Aff1, IDs10967025099842_cor1}, Abdel-Motaleb, Mohamed, El-Tawoosy, Mahmoud, Sanad, Mahmoud, Rizk, Sameh, El-Hashash, Maher